Genes Brain & BehaviorNeurosciencePeer-reviewed journal article
Selective behavioural impairments in mice heterozygous for the cross disorder psychiatric risk gene DLG2
Rachel PassiD, Niels HaaniD, Trevor HumbyiD, Lawrence S. WilkinsoniD, Jérémy HalliD, Kerrie L. ThomasiD
Abstract
Mutations affecting DLG2 are emerging as a genetic risk factor associated with neurodevelopmental psychiatric disorders including schizophrenia, autism spectrum disorder and bipolar disorder. Discs large homolog 2 (DLG2) is a member of the membrane-associated guanylate kinase protein superfamily of scaffold proteins, a component of the post-synaptic density in excitatory neurons and regulator of synaptic function and plasticity. It remains an important question whether and how haploinsuffiency of DLG2 contributes to impairments in basic behavioural and cognitive functions that may underlie symptomatic domains in patients that cross diagnostic boundaries. Using a heterozygous Dlg2 mouse model we examined the impact of reduced Dlg2 expression on functions commonly impaired in neurodevelopmental psychiatric disorders including motor co-ordination and learning, pre-pulse inhibition and habituation to novel stimuli. The heterozygous Dlg2 mice exhibited behavioural impairments in long-term motor learning and long-term habituation to a novel context, but not motor co-ordination, initial responses to a novel context, PPI of acoustic startle or anxiety. We additionally showed evidence for the reduced regulation of the synaptic plasticity-associated protein cFos in the motor cortex during motor learning. The sensitivity of selective behavioural and cognitive functions, particularly those dependent on synaptic plasticity, to reduced expression of DLG2 give further credence for DLG2 playing a critical role in specific brain functions but also a mechanistic understanding of symptom expression shared across psychiatric disorders.
- organism: mouse
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- Citations
- 14
- FWCI
- 2.11
- Field percentile
- top 13%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Behavioural and molecular characterisation of the Dlg2 haploinsufficiency rat model of genetic risk for psychiatric disorder
Sophie Waldron, Rachel Pass, … Dominic Michael Dwyer·Genes Brain & BehaviorPeer-reviewed·Jan 25, 2022
- Reduced expression of the psychiatric risk gene DLG2 (PSD93) impairs hippocampal synaptic integration and plasticity
Simonas Griesius, Cian O’Donnell, … Jack R. Mellor·NeuropsychopharmacologyPeer-reviewed·Feb 3, 2022
- Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivity
C. M. Grimm, S. Aksamaz, … D. Kaetzel·bioRxiv·May 14, 2018
- DLG2 knockout reveals neurogenic transcriptional programs underlying neuropsychiatric disorders and cognition
Bret Sanders, Daniel D’Andrea, … Eunju Shin·Nature CommunicationsPeer-reviewed·Jan 14, 2022
- Effect of Schizophrenia linked DRD2 gene mutations and correlation of social behavior with biochemical changes in a post-weaning isolated mouse model
Nivedhitha Mukesh, Pavan Kumar Divi, … Anil Annamneedi·bioRxiv·Nov 2, 2023
- Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and Schizophrenia: Towards neuromarkers of disease progression and risk
Ana A. Francisco, Douwe J. Horsthuis, … Sophie Molholm·NeuroImage ClinicalPeer-reviewed·Jan 1, 2020